Horizon 94 Medcomms Ltd 14656482 false 2024-03-01 2025-03-31 2025-03-31 The principal activity of the company is Medical consultancy Digita Accounts Production Advanced 6.30.9574.0 true 14656482 2024-03-01 2025-03-31 14656482 2025-03-31 14656482 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 14656482 bus:Micro-entities 2024-03-01 2025-03-31 14656482 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-03-31 14656482 bus:FilletedAccounts 2024-03-01 2025-03-31 14656482 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-03-31 14656482 bus:RegisteredOffice 2024-03-01 2025-03-31 14656482 bus:Director1 2024-03-01 2025-03-31 14656482 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-03-31 14656482 countries:EnglandWales 2024-03-01 2025-03-31 14656482 2023-02-12 2024-02-29 14656482 2024-02-29 14656482 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 14656482

Horizon 94 Medcomms Ltd

Unaudited Filleted Financial Statements

for the Period from 1 March 2024 to 31 March 2025

 

Horizon 94 Medcomms Ltd

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

1

 

Horizon 94 Medcomms Ltd

(Registration number: 14656482)
Balance Sheet as at 31 March 2025

2025
£

2024
£

Fixed assets

863

856

Current assets

71,780

45,120

Prepayments and accrued income

515

561

Creditors: Amounts falling due within one year

(40,285)

(26,550)

Net current assets

32,010

19,131

Total assets less current liabilities

32,873

19,987

Accruals and deferred income

(1,050)

(850)

 

31,823

19,137

Capital and reserves

31,823

19,137

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Bridgewater House
Century Park
Caspian Road
Altrincham
Cheshire
WA14 5HH

These financial statements were authorised for issue by the director on 25 April 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1 (2024 - 1).

For the financial period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Horizon 94 Medcomms Ltd

(Registration number: 14656482)
Balance Sheet as at 31 March 2025

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 25 April 2025
 

.........................................
Dr Sara A Shaw
Director